Molecular features of clinical outcomes in men with localized intermediate-risk prostate cancer treated with pre-operative apalutamide by J. Davis, AHN Hahn, GCM Manyam, BFC Chapin, MZ Zhang, YY Yu, CAP Pettaway, LC Chery, LLP Pisters, JFW Ward, JRG Gregg, JP Papadopoulos, ML Lozano, AH Hoang, BB Broom, XW Wang, CDH Huff, CJL Logothetis, PT Troncoso, PGP Pilie

Get full text